Movement Disorders Drugs

Random Miscellaneous Quiz

Can you name the Movement Disorders Drugs?

Quiz not verified by Sporcle

embed
 plays        
How to Play
HintAnswer
P-kinetics: Readily absorbed from intestines (depends on rate of gastric emptying and pH -- delayed by food). Some other AAs can compete for transport across the BBB.
SE: Asthenia, dizziness, GI disorders, & elevation of liver enzymes.
Contraindications: Prostatic hyperplasia, obstructive GI dz, & angle-closure glaucoma
P-kinetics: 2/3 appears in urine as metabolites within 8 hrs (homovanillic acid - HVA and dihydrocyphenylacetic acid - DOPAC). Best response is in the first few yrs of tx.
Contraindications: psychotic illness, MI hx, PVD, peptic ulcers
P-kinetics: Only 1-3% enters the brain across BBB unaltered. Peak plasma levels 1-2 hrs post PO dose. Plasma t1/2 = 1-2 hrs (pts vary -- dosing 3-4x/day).
P-kinetics: Rapid PO absorption, excreted unchanged in urine, gradually increase dose
MOA: Increases dopamine release & reduces dopamine reuptake into dopaminergic nerve terminals of substantia nigra neurons. Unknown MOA.
P-kinetics: Variable absorption from GI, peak plasma levels 1-2 hrs post PO dose. Excreted in bile & feces. Build up dose slowly over 2-3 mo to avoid adverse effects
Fluphenzaine class
MOA: Dopamine precursor able to cross the BBB where it is decarboxylated by dopa decarboxylase to form dopamine.
SE: Insomnia when taken late in the day
Levodopa class
MOA: Central (brain) anti-cholinergic
P-kinetics: Given PO. Loses effectiveness over time.
Selegiline class
Pramipexole class
SE: Ergoline-induced toxicity effects unlikely. Postural hypotension, fatigue, somnolence, peripheral edema, nausea, constipation, dyskinesias, & confusion.
MOA: Somewhat selective MAO-B inhibitors. Retard the breakdown of dopamine
Use: Huntington's dz pts w/ psychosis or disruptive behavior. Also helpful w/ chorea
SSRI class
Interactions: Vitamin B6 enhances the extracerebral metabolism of L-dopa. MAOI w/ L-dopa can --> HTNive crisis if given within 2 weeks of each other.
SE: CV: Increased HR, PVCs, A fib (rare), postural hypotension, HTN (usually in the presence of non-specific MAOI or with large doses).
P-kinetics: Start at low dose & gradually increase
SE: Increased L-dopa toxicity (dyskinesias, nausea, & confusion), diarrhea, abd pain, orthostatic hypotension, sleep disturbances, & orange urine.
P-kinetics: SQ. Rapid onset ~ 10 min. Duration 2 hrs
Tetrabenxine class
SE: Nausea (pretreat w/ anti-emetic - trimethobenzamide or domiperidone), dyskinesias, drowsiness, sweating, hypotension
P-kinetics: Only helpful for Huntington's dz chorea at very high doses
Use: May improve tremor & rigidity in Parkinsons. Little effect on bradykinesia.
Use: Similar to Bromocriptine, but more effective. May benefit pts not receiving L-dopa. Aids pt w/ response fluctuations to L-dopa
MOA: D2 receptor agonist (partial D1 agonist)
HintAnswer
Riluzole class
Group P-kinetics: Advantages: No enzymatic conversion required, crosses BBB w/o competing for amino acid transporter. No potentially toxic metabolites
Use: Monotherapy for mild Parkinsonism or combo tx for advanced pts. Reduces L-dopa dose & smooths response fluctuations. Putative neuroprotective effects (scavenges free radicals)
P-kinetics: Similar to Pramipexole
Pergolide class
Use: Most effective drug in tx of Tourette's
Interactions: Should not be taken w/ meperidine, TCAs, serotonin reuptake inhibitors, or in combo w/ nonspecific MAOIs
Carbidopa + levidopa (1:10 or 1:4)
SE: Other: dry mouth, blurred vision, mydriasis, urinary retention, n/v, constipation, tachycardia, increased IOP.
SE: If adverse effects become too severe withdraw gradually. break for 3-21 days, and reinstate gradually
Use: prolong ALS survival by months
Tolcapone class
P-kinetics: Start with a small dose
Ropinirole class
Use: Similar to Pramipexole
MOA: Preferential affinity for D3 family of receptors
MOA: Not completely known. Inhib effects on glutamate-R, NMDA antag, Inactivation of voltage gated Na+ channels. Interferes w/ intracellular events post excitatory AA-R activation
Apomorphine class
SE: Mental Disturbances: confusion, hallucinations, delusions, other psychiatric reactions.
Trihexyphenidyl class
Carbidopa class
Olanzapine class
SE: GI (L-dopa alone): anorexia, n/v (avoid anti-emetics like phenothiazines d/t their extrapyramidal effects -- dopamine antagonist; carbidopa reduces these effects.
Use: Increases amount of L-dopa able to cross the BBB. Combo with L-dopa allows for L-dopa dose reduction up to 85%.
SE: Dyskinesias: chorea, ballismus, athetosis, dystonia, myoclonus, tics, tremors. Behavioral effects: anxiety/ agitation, insomnia/ somnolence, confusion/ delusions/ hallucination
SE: May be hepatotoxic - (needs signed pt consent & liver monitoring Q 2 wks x 1 yr)
TCA class
Quetiapine class
Use: alleviation of chorea if refractory to atypical
P-kinetics: Response can decline over time or stop completely. Start at small dose & escalate as effects diminish. Wearing off rxs. Toxicity concern is supersensitivity develpmnt -
MOA: Prevents the metabolism of L-dopa --> 3-O-methyldopa (3OMD) by Catechol-0-methyltransferase
Contraindications: psychotic pts, angle closure glaucoma (Increased IOP), active peptic ulcers, hx of melanoma (melanin precursor)
HintAnswer
SE: GI: anorexia, n/v, constipation, dyspepsia, peptic ulcers, symptoms of reflux esophagitis. CV: postural hypotension & cardiac arrhythmias. Dyskinesias.
Carbamazepine class
MOA: D1 and D2 receptor agonist
Rasagiline class
Risperidone class
SE: HA, nasal congestion, increased arousal, pulmonary infiltrates, ergoline-induced s/s, erythromelagia, vasospasm, & pleural or retroperitoneal fibroses.
Bromocriptine class
P-kinetics: Well absorbed orally. T1/2 ~ 12 hrs. Hepatic metabolism (cytochrome P450, CYP1A2) -- caution in pts w/ hepatic insufficiency.
Haloperidol class
SE: CNS: drowsiness, mental slowness, inattention, restless, confusion, agitation, delusions, hallucinations, & mood changes.
Procyclidine class
Reserpine class
SE: May interfere with uptake - Rx metabolizes L-dopa into 3-methyldopa which competes for active transport across the BBB.
MOA: Inhibits the L-dopa --> dopamine conversion by dopa decarboxylase in the periphery (does not cross BBB).
Clonidine class
Use: depression associated with Huntington's disease
Biperiden class
Use: Temporary relief of off-period akinesia in Parkinsons. Also used to tx ED.
MOA: Pure D2 receptor agonist
Use: alleviation of chorea
Phenothiazine class
Clonazepam class
Amantadine class
Use: Can be used as 1st line tx for Parkinson's dz - often in combo w/ Sinemet. Commonly used to tx hyperprolactinemia.
P-kinetics: Note: Antidepressant MAOIs are either nonspecific or inhibit MAO-A more specifically (5-HT & NE)
Use: Gold standard in Parkinson's dz - most efficacious treatment
Use: Reduced response to fluctuations w/ L-dopa. Decreased L-dopa clearance. Decreased dopa decarboxylase --> compensatory increase in COMT.
Use: Enhance & prolong the effects of L-dopa; reduce response fluctuations; lowers necessary dose of L-dopa. ?Antioxidant properties?
Benzotropine class
Entacapone class
Butyrophenones class
Orphenadrine class

Friend Scores


  Player Best Score Plays Last Played
You You haven't played this game yet.

You Might Also Like...

Extras

Created Oct 8, 2011ReportNominate
Tags:disorder, drug, movement